the use of generally lower dosages of captopril in patients with normal or slightly impaired renal function has resulted in a generally low incidence of rash ( 0.5 to 4 % ) , dysgeusia ( 0.1 to 3 % ) , proteinuria ( 0.5 % ) , neutropenia ( 0.3 % during first 3 months ) and symptomatic hypotension ( 0.1 to 3 % ) .
C0006938
captopril
C0020649
hypotension